Ian Goodfellow
Ian is a Principal Scientist at Google DeepMind. He first became involved in AI research at the Stanford AI Lab and has been a deep learning researcher since circa 2008. He developed the first defenses against adversarial examples, was among the first to study the security and privacy of neural networks, and his invention of Generative Adversarial Networks in 2014 helped to popularize the field of machine learning security and privacy. He is the lead author of the MIT Press textbook Deep Learning (www.deeplearningbook.org). As a research scientist at Google and OpenAI, he has contributed to machine learning security and privacy and been an advocate for responsible AI development and diversity and inclusion in the AI industry. He has also served as Apple Special Project Group’s Director of Machine Learning. Ian was listed among MIT Technology Review’s 35 Innovators under 35 in 2017 and Foreign Policy’s 100 Global Thinkers in 2019.
Phillip Alvelda
Dr. Phillip Alvelda, is the CEO and Chairman of Brainworks Foundry, Inc., a U.S. based developer of AI-enhanced healthcare technologies and services. Prior to Brainworks, Dr. Alvelda was a Program Manager at the Defense Advanced Research Projects Agency [DARPA] Biological Technologies Office where he developed and ran national scale R&D programs and technologies at the intersection of engineering and biology.
Prior to DARPA, Dr. Alvelda was the founding CEO of MobiTV, which launched the world’s first live television service over mobile networks, for which he was awarded an Emmy by the Academy of Motion Pictures, selected by Fast Company as the US’s 15th most influential high-tech entrepreneur, and has received numerous other industry awards for innovation and market leadership. He is a regular invited speaker at science, technology, and education industry events, including the World Economic Forum where he was chosen as a “Technology Pioneer” in 2007.
Ziyad Al-Aly
Dr. Al-Aly a physician-scientist; he directs the Clinical Epidemiology Center and serves as the Chief of Research and Development Service at the VA Saint Louis Health Care System. He is a clinical epidemiologist with broad interests including pharmacoepidemiology, environmental epidemiology, global health, and most recently short- and long-term effects of COVID 19 on health outcomes.
He has published extensively in several major journals including Nature, Nature Medicine, BMJ, JAMA, JAMA-Internal Medicine, Lancet, NEJM, and others. According to Google Scholar, his work has been cited more than 50,000 times. His work is frequently featured in major national and international media outlets including New York Times, NPR, BBC, CNN, the Guardian, Bloomberg, The New Yorker, the Atlantic, and several others.
